Companies / Santa Cruz Biotechnology / Palmitoylethanolamide-3
Santa Cruz Biotechnology

Palmitoylethanolamide-3 | Santa Cruz Biotechnology

FAAH Inhibitor, GPR55 Activator, PPAR alpha Activator, Palmitoylethanolamide is an endogenous cannabinoid agonist, FAAH inhibitor, and PPARα agonist.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.

  • See More